Mediation of entry of human immunodeficiency virus-1 into alveolar macrophages by CD4 without facilitation by surfactant-associated protein-a

被引:9
作者
Guay, LA
SierraMadero, JG
Finegan, CK
Rich, EA
机构
[1] CASE WESTERN RESERVE UNIV,DEPT MED,CLEVELAND,OH 44106
[2] UNIV HOSP CLEVELAND,CLEVELAND,OH 44106
关键词
RECOMBINANT SOLUBLE CD4; MONONUCLEAR PHAGOCYTES; HUMAN-MONOCYTES; HIV-INFECTION; T-CELLS; MONOCLONAL-ANTIBODIES; INVITRO INFECTION; FC RECEPTOR; II CELLS; TYPE-1;
D O I
10.1165/ajrcmb.16.4.9115753
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanism of uptake of human immunodeficiency virus-1 (HIV-1) into alveolar macrophages (AM), freshly isolated blood monocytes (MN), and cultured MN (CM) was investigated focusing on the role of CD4 and of surfactant-associated protein A (SP-A). By radioimmunoassay which obviated the problems of auto- and nonspecific fluorescence of more differentiated macrophages, each of the macrophage populations studied expressed CD4. Semiquantitative polymerase chain reaction was performed to assess uptake of HIV-1(JR-FL) into cells. OKT4a (directed against CD4) blocked uptake of HIV-1 into CM, AM, and MN by 67 to 100%. OKT4 (directed against another epitope of CD4) had a smaller and less consistent effect (0-90%), and control antibodies showed minimal effects and only at supersaturating concentrations. SP-A had no effect on uptake of HIV-1 into AM. SP-A also had no consistent effect on production of HIV-1(JR-FL) by AM infected in vitro (p24 antigen ELISA). Thus CD4 is the major receptor for HIV-1 in mononuclear phagocytes, including AM, and SP-A does not modulate entry.
引用
收藏
页码:421 / 428
页数:8
相关论文
共 51 条
  • [1] CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1
    Alkhatib, G
    Combadiere, C
    Broder, CC
    Feng, Y
    Kennedy, PE
    Murphy, PM
    Berger, EA
    [J]. SCIENCE, 1996, 272 (5270) : 1955 - 1958
  • [2] SUSCEPTIBILITY TO INFECTION BY THE HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) CORRELATES WITH T4 EXPRESSION IN A PARENTAL MONOCYTOID CELL-LINE AND ITS SUBCLONES
    ASJO, B
    IVHED, I
    GIDLUND, M
    FUERSTENBERG, S
    FENYO, EM
    NILSSON, K
    WIGZELL, H
    [J]. VIROLOGY, 1987, 157 (02) : 359 - 365
  • [3] BRODSKYDOYLE B, 1987, J IMMUNOL, V138, P1150
  • [4] DETECTION OF HTLV-III RNA IN LUNGS OF PATIENTS WITH AIDS AND PULMONARY INVOLVEMENT
    CHAYT, KJ
    HARPER, ME
    MARSELLE, LM
    LEWIN, EB
    ROSE, RM
    OLESKE, JM
    EPSTEIN, LG
    WONGSTAAL, F
    GALLO, RC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (17): : 2356 - 2359
  • [5] SOLUBLE CD4 BLOCKS THE INFECTIVITY OF DIVERSE STRAINS OF HIV AND SIV FOR T-CELLS AND MONOCYTES BUT NOT FOR BRAIN AND MUSCLE-CELLS
    CLAPHAM, PR
    WEBER, JN
    WHITBY, D
    MCINTOSH, K
    DALGLEISH, AG
    MADDON, PJ
    DEEN, KC
    SWEET, RW
    WEISS, RA
    [J]. NATURE, 1989, 337 (6205) : 368 - 370
  • [6] MACROPHAGE-TROPIC STRAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 UTILIZE THE CD4 RECEPTOR
    COLLMAN, R
    GODFREY, B
    CUTILLI, J
    RHODES, A
    HASSAN, NF
    SWEET, R
    DOUGLAS, SD
    FRIEDMAN, H
    NATHANSON, N
    GONZALEZSCARANO, F
    [J]. JOURNAL OF VIROLOGY, 1990, 64 (09) : 4468 - 4476
  • [7] QUANTITATIVE IMMUNOCYTOFLUOROGRAPHIC ANALYSIS OF CD4 SURFACE-ANTIGEN EXPRESSION AND HIV-INFECTION OF HUMAN PERIPHERAL-BLOOD MONOCYTE MACROPHAGES
    CROWE, S
    MILLS, J
    MCGRATH, MS
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1987, 3 (02) : 135 - 145
  • [8] FULL-LENGTH RECOMBINANT CD4 AND RECOMBINANT GP120 INHIBIT FUSION BETWEEN HIV INFECTED MACROPHAGES AND UNINFECTED CD4-EXPRESSING T-LYMPHOBLASTOID CELLS
    CROWE, SM
    MILLS, J
    KIRIHARA, J
    BOOTHMAN, J
    MARSHALL, JA
    MCGRATH, MS
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (08) : 1031 - 1037
  • [9] DRICKAMER K, 1987, J BIOL CHEM, V262, P13877
  • [10] A HUMAN-SERUM MANNOSE-BINDING PROTEIN INHIBITS INVITRO INFECTION BY THE HUMAN IMMUNODEFICIENCY VIRUS
    EZEKOWITZ, RAB
    KUHLMAN, M
    GROOPMAN, JE
    BYRN, RA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (01) : 185 - 196